Rituximab is effective as first line therapy in the management of steroid sensitive, but dependent/relapsing adult Nephrotic syndrome.

Authors
Kohli Harbir
Jha V.
Raja Ramachandran
Rao Indu
Pinnamaneni Siva
Ranjana Minz
Ritambhra Nada
Vivek Kumar
Manish Rathi
Gupta Krishan
Type of Publication
Journal Article
Year of Publication
2017
Journal
Nephrology (Carlton)
DOI
10.1111/nep.12924
Language
Eng
ISSN Number
1440-1797
Volume
22
Issue
9
Number of Pages
731-732
Links to full text
Search Publications
Open Publication